PiB & florbetapir provide consistent results for Alzheimer’s eval

January 10, 2013

Beta-amyloid status was highly consistent regardless of the radiotracer used, according to results of a small study of individuals who underwent PET imaging exams with Pittsburgh compound B (PiB) and florbetapir. The findings were published in the January issue of The Journal of Nuclear Medicine .